Floeystad Hans Kristian, Holter Jan Cato, Husebye Einar, Siljan William Ward, Berild Dag, Holm Are Martin, Heggelund Lars
Department of Internal Medicine, Sorlandet Hospital, 4615 Kristiansand, Norway.
Department of Internal Medicine, Drammen Hospital, Vestre Viken Hospital Trust, 3004 Drammen, Norway.
J Clin Med. 2023 Jun 8;12(12):3924. doi: 10.3390/jcm12123924.
In pneumococcal community-acquired pneumonia (CAP), bacteremia is associated with increased mortality, but initial clinical severity scores frequently fail to identify bacteremic patients at risk. We have previously shown that gastrointestinal symptoms are common among patients admitted to the hospital with pneumococcal bacteremia. The aim of this study was to examine gastrointestinal symptoms and inflammatory responses in bacteremic and non-bacteremic pneumococcal CAP in a prospective cohort of immunocompromised and immunocompetent patients hospitalized with CAP.
Logistic regression analysis was used to estimate the predictive value of gastrointestinal symptoms for pneumococcal bacteremia in patients with CAP. The Mann-Whitney test was used to compare inflammatory responses in patients with bacteremic vs. non-bacteremic pneumococcal CAP.
Eighty-one patients with pneumococcal CAP were included, of whom 21 (26%) had bacteremia. Immunocompetent patients with pneumococcal CAP had an odds ratio of 16.5 (95% CI 3.0-90.9, = 0.001) for bacteremia if nausea was present, whereas no such association was found in the immunocompromised patients (OR 0.22, 95% CI 0.02-2.05, = 0.18). The serum levels of C-reactive protein, procalcitonin and interleukin 6 were significantly higher in the patients with bacteremic pneumococcal CAP compared to non-bacteremic pneumococcal CAP patients ( < 0.001, = 0.005, and = 0.019, respectively).
In immunocompetent patients hospitalized with pneumococcal CAP, nausea may be a predictor of bacteremia. Bacteremic pneumococcal CAP patients display an increased inflammatory response compared to non-bacteremic pneumococcal CAP patients.
在肺炎球菌社区获得性肺炎(CAP)中,菌血症与死亡率增加相关,但初始临床严重程度评分常常无法识别有风险的菌血症患者。我们之前已经表明,胃肠道症状在因肺炎球菌菌血症入院的患者中很常见。本研究的目的是在一组因CAP住院的免疫功能低下和免疫功能正常的患者前瞻性队列中,检查菌血症性和非菌血症性肺炎球菌CAP患者的胃肠道症状和炎症反应。
采用逻辑回归分析来估计CAP患者中胃肠道症状对肺炎球菌菌血症的预测价值。采用曼-惠特尼检验比较菌血症性与非菌血症性肺炎球菌CAP患者的炎症反应。
纳入了81例肺炎球菌CAP患者,其中21例(26%)有菌血症。肺炎球菌CAP免疫功能正常的患者若出现恶心,菌血症的比值比为16.5(95%可信区间3.0 - 90.9,P = 0.001),而在免疫功能低下的患者中未发现这种关联(比值比0.22,95%可信区间0.02 - 2.05,P = 0.